Go to deals
Healthcare

MediCA klinika has acquired Lieporiu Seimos Gydytoju Centras

MediCA klinika, the largest private clinics chain in Lithuania, has acquired Lieporiu Seimos Gydytoju Centras, a private primary care clinic in Siauliai city.

MediCA klinika operates 31 clinics in 16 cities, with revenues of approximately US$35 million. It belongs to CGP Management, a privately owned holding company which also owns the leading pharmacy chain in Lithuania. This acquisition will allow MediCA klinika to expand its market coverage in the country.

Lieporiu Seimos Gydytoju Centra is the largest private clinic in Siauliai city, the fourth largest city of Lithuania, with over 5,000 registered patients.

Oaklins’ team in Lithuania acted as advisor for the buyer throughout the acquisition process, from searching for add-on acquisition targets in Lithuania until final completion.

Parties

Talk to the deal team

 Natalja  Titova

Natalja Titova

Associate Partner
Vilnius, Lithuania
Oaklins Baltics
 Mindaugas  Matulaitis

Mindaugas Matulaitis

Associate Partner
Vilnius, Lithuania
Oaklins Baltics

Related deals

Alcidion has raised capital
Healthcare

Alcidion has raised capital

Alcidion Group Ltd. (ASX:ALC) has raised capital via an institutional placement. The placement was well supported by existing shareholders whilst also welcoming several new institutional shareholders to the register. Proceeds from the raise will provide Alcidion with maximum flexibility and ensure a strong balance sheet to execute on its market opportunities and enable the firm to continue to drive revenue growth.

Learn more
A group of Chilean investors has acquired Farmacias Ahumada
Consumer & Retail | Healthcare

A group of Chilean investors has acquired Farmacias Ahumada

A group of Chilean investors has acquired Farmacias Ahumada S.A. from Walgreens Boots Alliance.

Learn more
Shield Therapeutics has completed a fundraising
Healthcare

Shield Therapeutics has completed a fundraising

Shield Therapeutics plc has raised funds to bolster the expansion of ACCRUFeR®, the sole FDA-approved therapy for iron deficiency and to drive the business. Additionally, it positions the company for further investments.

Learn more